Think AI's Prospects Are Overblown? Try This Beaten-Down Growth Stock.
Is artificial intelligence a bubble? That's the trillion-dollar question. Large language models ( LLMs ) like those that power OpenAI's ChatGPT are certainly impressive, capable of generating coherent text, images, and functional code.
HYLENR and TakeMe2Space to test LENR Powered Compute Modules
Ink MoU to test and experiment HYLENR's Low-Energy Nuclear Reaction ( LENR ) technology for space-based compute infrastructure
Fin Min gives hopes on prices Indian consumers pay while flagging trade risks - ETCFO
The Finance Ministry's Monthly Economic Review for February noted a moderation in inflation for vegetables, cereals, and pulses. It also highlighted increased trade risks due to tariff developments, which have affected global investment and trade flows.
Brazil Potash Announces Participation In Diversibram 2025 - Brazil Potash ( AMEX:GRO )
MANAUS, Brazil, March 26, 2025 ( GLOBE NEWSWIRE ) -- Brazil Potash Corp. ( "Brazil Potash" or the "Company" ) ( NYSE-American: GRO ) , a developer and builder of Brazil's largest potash fertilizer project, announced today that its wholly-owned subsidiary, Potássio do Brasil Ltda., will ...
Hold Nvidia? Here Are 2 Unstoppable AI Stocks You Can Also Buy.
Many artificial intelligence ( AI ) stocks have sold off recently, presenting compelling buying opportunities for patient investors. But folks with a sizable amount of their portfolio in names like Nvidia ( NASDAQ: NVDA ) may be looking for other ideas.Here's why Vertiv Holdings ( NYSE: VRT ) and ...
Nokia's Dual Breakthrough: DFN Network Upgrade & Corteca Expansion - Nokia ( NYSE:NOK )
Nokia upgraded DFN's IP core network in Germany, boosting connectivity from 100G to 400G with 800G potential. Nokia launches several new applications that help CSPs unlock new revenue opportunities.
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics' TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the 48-week interim analysis are expected in the middle of 2025 Cyclo Therapeutics' TransportNPC™ ...
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals - Cyclo Therapeutics ( NASDAQ:CYTH ) , Rafael Holdings ( NYSE:RFL )
NEWARK, N.J. and GAINESVILLE, Fla., March 26, 2025 ( GLOBE NEWSWIRE ) -- Rafael Holdings, Inc. RFL, and Cyclo Therapeutics, Inc. CYTH today announced the closing of their business combination following approval by shareholders of both companies.